The NO synthase inhibitors L-Name and L-NMMA, but not L-arginine, block the mammalian nicotinic acetylcholine receptor channel

Michaela Scheller, M. Blobner, C. Von Loewenich, H. Schneck, J. Stadler, C. Franke, E. Kochs

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Abstract

(1) Nitric oxide (NO) synthase inhibitors (NOS-I) such as l-Name (N(G)-nitro l-arginine methyl ester) and l-NMMA (N(G)-monomethyl l-arginine) may enhance anesthesia indirectly by inhibiting the NO pathway. Moreover, NOS-I interact directly with receptor proteins. In an animal study, l-NMMA potentiated muscle relaxants. (2) The present experiments investigate the effects of l-NMMA, l-Name, and l-arginine on the nicotinic acetylcholine receptor channel (nAChR) using patch clamp techniques and a piezo-driven application system. Both NOS-I appear to directly interact with the nAChR in the open as well as in the closed conformation. l-Arginine has no effect. Copyright (C) 1998 Elsevier Science Ireland Ltd.

Original languageEnglish
Pages (from-to)109-113
Number of pages5
JournalToxicology Letters
Volume100-101
DOIs
StatePublished - 23 Nov 1998
Externally publishedYes

Keywords

  • Channel blocking
  • Inhibitors
  • NO synthase

Fingerprint

Dive into the research topics of 'The NO synthase inhibitors L-Name and L-NMMA, but not L-arginine, block the mammalian nicotinic acetylcholine receptor channel'. Together they form a unique fingerprint.

Cite this